It is well documented that breastfeeding benefits babies. But a new study of Australian mums…
View More Breastfeeding helps to protect mums’ hearts, new study finds
Caterpillars could hold the secret to new treatment for osteoarthritis
A substance from a fungus that infects caterpillars could offer new treatment hope for sufferers…
View More Caterpillars could hold the secret to new treatment for osteoarthritis
Solution sought to ‘sticky’ staph situation
David Heinrichs faces a potentially deadly adversary found on the skin of almost 30 per…
View More Solution sought to ‘sticky’ staph situation
8 Simple Ways to Adopt a Natural Lifestyle
As a true Californian, I grew up practicing yoga and eating organic produce grown in…
View More 8 Simple Ways to Adopt a Natural Lifestyle
Early-life exposure to microbiota restricts colon cancer later in life, study finds
Exposure to microbiota, or microorganisms such as bacteria, in the early stages of life plays…
View More Early-life exposure to microbiota restricts colon cancer later in life, study finds
Mystery infections traced to blood-shedding religious ritual
Add self-flagellation to the list of ways to get a dangerous viral blood infection. Researchers…
View More Mystery infections traced to blood-shedding religious ritual
When can kids return to play after a concussion?
(HealthDay)—Though coaches and parents are more alert to the need for emergency attention after young…
View More When can kids return to play after a concussion?
Promoting safer routes to school through citizen science
Parents with a knack for citizen science are helping their children walk or bike to…
View More Promoting safer routes to school through citizen science
Scientists demonstrate use of ultrasound to alter inflammatory and metabolic response
GE Research and Feinstein Institute for Medical Research bioelectronic medicine teams have demonstrated potentially breakthrough…
View More Scientists demonstrate use of ultrasound to alter inflammatory and metabolic response
Long-acting regimen noninferior to daily ART for HIV-1
(HealthDay)—Monthly long-acting (LA) cabotegravir (CAB) and rilpivirine (RPV) are noninferior to daily regimens for patients…
View More Long-acting regimen noninferior to daily ART for HIV-1